Go back to the Europarl portal

Choisissez la langue de votre document :

  • bg - български
  • es - español
  • cs - čeština
  • da - dansk
  • de - Deutsch
  • et - eesti keel
  • el - ελληνικά
  • en - English (Selected)
  • fr - français
  • ga - Gaeilge
  • hr - hrvatski
  • it - italiano
  • lv - latviešu valoda
  • lt - lietuvių kalba
  • hu - magyar
  • mt - Malti
  • nl - Nederlands
  • pl - polski
  • pt - português
  • ro - română
  • sk - slovenčina
  • sl - slovenščina
  • fi - suomi
  • sv - svenska
Parliamentary questions
8 June 2017
Answer given by Ms Bieńkowska on behalf of the Commission

The Standing Committee on the Law of Patents (SCP) of the World Intellectual Property Organisation (WIPO) is a committee of WIPO Member States' experts that meets twice per year to discuss patent related issues. There are several issues on the agenda of the SCP.

The nature of the discussions remains at the level of an exchange of views and best practices. The Commission does not have an authorisation to open negotiations on any of the issues under discussion at the SCP and there is no consensus amongst the WIPO members as to the desirability to engage in such negotiations at this stage.

If any of the current discussions were to turn into negotiations and the Commission received an authorisation from the Council to engage in them, the Commission would ensure full information of the European Parliament in accordance with the framework Agreement on relations between the European Parliament and the Commission(1).

The Commission is in contact with stakeholders on a regular basis, also prior to SCP discussions, and coordinates with Member States interventions at the SCP in view of the fact that the current discussions consist of an exchange of views and best practices.

In this context, the Commission welcomes the view on the High Level Panel report taken by the European Parliament in paragraph 53 of its own-initiative Resolution of 2 March 2017 on EU options for improving access to medicines(2).

(1)OJ 2010, L 304/47.

Last updated: 12 June 2017Legal notice